MERGERS & ACQUISITIONS in the industry Is There Life After the Financial Crash or Do We Need a Defibrillator?

Add to your list(s) Download to your calendar using vCal

• MICHEAL LEWIS, Chairman & CEO Rainer Technology, GLYN EDWARDS, Interim CEO BioIndustry Association, CHRISTOPHER COE, Managing Partner European Life Science Practice CTPartners
• Thursday 10 May 2012, 18:30-20:30
• LT1, Judge Business School, University of Cambridge.

If you have a question about this talk, please contact Lalarukh Haris.

PANEL DISCUSSION & INSIGHT into the Biotech Industry:

MICHEAL LEWIS , Chairman & CEO Rainer Technology ‘M&A in Medtech, Diagnostics, Biotech, Dental & Pharma, what are the differences?’

GLYN EDWARDS , Interim CEO BioIndustry Association ‘Biotech, boom time or doom time for M&A?’

CHRISTOPHER COE , Managing Partner European Life Science Practice CTPartners ‘The corporate view of M&A, the inside-out view of M&A targets’

SIGN UP HERE : http://mandaseries.eventbrite.com/

This talk is part of the Oxbridge Biotech Roundtable series.

This talk is included in these lists:

• LT1, Judge Business School, University of Cambridge

Note that ex-directory lists are not shown.